(Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ... MELBOURNE, Australia, Sept. 23 ...

Genetic Technologies Limited (NASDAQ:GENE)任命自愿管理人的决定与InvestingPro强调的几个令人担忧的财务指标相一致。该公司的市值仅为370万美元，反映了其当前的困境。InvestingPro提示显示，GENE正在迅速消耗现金，其短期债务超过了流动资产，这可能促使公司决定进入自愿管理。

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate.

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced an extension to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Genetic Technologies ( ASX:GTG ) Full Year 2024 Results Key Financial Results Revenue: AU$9.63m (down 6.9% from FY... Simply Wall St. Insiders who bought AU$80.3k worth of Genetic Technologies Limited ...

View Genetic Technologies Limited (GENE) current and estimated P/E ratio data provided by Seeking Alpha.